课题基金 / 基金详情

MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS

MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS
母体 DDAVP 用于治疗水少症
批准号：
3764731
负责人：
MICHAEL G ROSS
金额：
$0.0万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3764731
关键词：
amniotic fluid arginine vasopressin body water hormone therapy human pregnant subject human therapy evaluation pregnancy disorder pregnancy disorder chemotherapy

项目摘要

项目成果

MICHAEL G ROSS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Potential therapeutic utility of maternal dDAVP for patients with oligo- hydramnios (insufficient amniotic fluid). Despite the significant consequences of oligohydramnios, there are no established means to increase amniotic fluid volume prior to labor. Recent studies indicate the potential of a novel treatment for oligohydramnios, utilizing maternal administration of a drug (dDAVP) to hydrate mother & secondly baby with amniotic fluid. The baby hydrates in relation to mother & increases its urine production and thus amniotic fluid.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RELATION OF PLASMA VOLUME EXPANSION TO VASOPRESSIN
FETAL ROLE IN OLIGOHYDRAMIOS
PRE-ECLAMPSIA--CLINICAL AND HORMONAL RESPONSE TO ANTEPARTUM VOLUME EXPANSION
RELATION OF PLASMA VOLUME EXPANSION TO VASOPRESSIN
海外基金